CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients
The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure.
Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test
The test, which was developed by researchers at the Cleveland Clinic and the University of Alabama, looks for RNA molecules in urine that indicate rejection.
CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test
The partners are planning to develop and commercialize UroMap, a urine-based gene-expression test for acute cellular rejection in kidney transplant recipients.
CareDx Q1 Revenues Up 48 Percent
The company reported $38.4 million in total revenues for the quarter and said testing services revenues rose 46 percent year over year.
The firm believes the multi-part stratification project will help further commercialization of its KidneyIntelX blood-based assay for acute and chronic kidney disease.